- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 189-203 of
1,124 results
No. 2-16
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-16 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-4
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-4 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-8
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-8 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-5
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-5 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-12
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-12 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-15
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-15 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-1
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-1 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-14
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-14 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-10
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-10 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-11
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-11 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-9
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-9 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
... William J Jusko, PhD Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 ...
Document
IPR2024-00009, No. 2025 Exhibit - EX2025 Excerpt of Opening Expert Report of William J Jusko, PhD Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22
|
|
Cite Document
... of Dr Paul Dalby Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 ...
Document
IPR2024-00009, No. 2026 Exhibit - EX2026 Excerpt of Opening Expert Report of Dr Paul Dalby Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 MD 0303
|
|
Cite Document
... of Dr John Bantle Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 ...
Document
IPR2024-00009, No. 2024 Exhibit - EX2024 Excerpt of Opening Expert Report of Dr John Bantle Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 MD 030
|
|
Cite Document
